ICGEB awarded for "Most promising vaccine for emerging diseases in India"

tl_files/News2013/NovovaxAward.png

At the Vaccine World Summit 2013, held 5-8 March in Pune, India, the Novavax, CPLB and ICGEB collaboration is honored as having the "Most Promising Vaccine for Emerging Diseases in India."

This competitive award recognized the progress made by the International Centre for Genetic Engineering and Biotechnology (ICGEB)Novavax, Inc (Nasdaq:NVAXand Cadila Pharmaceuticals Ltd. Biologicals (CPLB) to develop a new and effective malaria vaccine. It was one of five inaugural awards honoring achievements in India's vaccine industry.

The ICGEB/Novavax/CPLB collaboration was established in 2012 to combine the advanced vaccine technology of Novavax with the malaria vaccine research capabilities of ICGEB and vaccine manufacturing capability of CPLB. The project is being funded by India's Department of Biotechnology Vaccine Grand Challenge Program and managed by the Malaria Vaccine Development Program, a New Delhi-based nonprofit organization established to support the development of malaria vaccines.

"The technology from Novavax has allowed us to explore a novel delivery platform to develop malaria vaccines and the initial results from pre-clinical studies are exciting" said Professor Virander S. Chauhan, Director, ICGEB New Delhi.

"We thank our industry peers for honoring this important work and congratulate our colleagues in India for their outstanding progress toward the development of an effective malaria vaccine," said Stanley C. Erck, President and CEO of Novavax. "Malaria remains a major public health problem in many parts of the tropical world and we are committed to identifying a safe and effective vaccine that can prevent its spread and devastating effects."

Press releases:

8 March 2013
Nasdaq omx GlobeNewswire: Novavax, CPLB and ICGEB Collaboration Honored for Malaria Vaccine Progress at Vaccine World Summit India 2013

4-traders Novavax, Inc.  (NVAX): Novavax, CPLB and ICGEB Collaboration Honored for Malaria Vaccine Progress at Vaccine World Summit India 2013

TheStreet: Novavax, CPLB and ICGEB Collaboration Honored for Malaria Vaccine Progress

CNBC: Novavax, CPLB and ICGEB Collaboration Honored..

11 March 2013
PBR Drug Research Drug Discovery & Development: Vaccine World Summit India 2013 honors collaboration for malaria vaccine development

VN daily Vaccine News: Novavax, ICGEB and CPLB collaboration honored for malaria vaccine progress

13 March 2013
Hindustan Times: Malaria vaccine: Indian scientists take a leap forward

14 March 2013
MENAFN.COM Middle East North Africa Financial Network: Malaria vaccine: Indian scientists take a leap forward

Further reading:

IMIPAC Vaccine World Summit 2013

Australian Prime Minister visits ICGEB New Delhi

ICGEB New Delhi - developments for Malaria Vaccine

 

Go back

Cod. Fisc. 90031700322

AREA Science Park
Padriciano 99
34149 Trieste, ITALY
Tel: +39-040-37571
Fax: +39-040-226555
icgebicgeb.org
Address book

 

 

 

 

 

 

 tl_files/iTunes_Badge_Color_master_10251024.png

 

tl_files/FB.png tl_files/Twitter_logo_blue-1def.png tl_files/rss.png
tl_files/LinkedIn-InBug-2CRev2.png tl_files/YouTube.png